Literature DB >> 24936562

Serum monocyte chemokine protein-1 levels before and after parathyroidectomy in patients with primary hyperparathyroidism.

Hemal Patel1, Stanley Trooskin2, Sue Shapses3, Wei Sun1, Xiangbing Wang1.   

Abstract

OBJECTIVE: To investigate the effects of parathyroidectomy on serum monocyte chemokine protein-1 (MCP-1) levels in patients with primary hyperparathyroidism (PHPT).
METHODS: Forty-three PHPT patients, age 56 ± 12 years, underwent minimally invasive parathyroidectomy. Serum samples were collected at 0 and 15 to 20 minutes after parathyroid adenoma removal. Serum samples were stored at -70°C until time of assay.
RESULTS: In 40 PHPT patients with a single adenoma, MCP-1 levels decreased from 342 ± 103 to 250 ± 77 pg/mL (P<.001) 15 to 20 minutes after parathyroid adenoma removal. MCP-1 levels were positively correlated with intact parathyroid hormone (PTH) levels (R = 0.47; P<.01). In 3 PHPT patients with double parathyroid adenoma, MCP-1 levels did not decrease after removal of the first adenoma but decreased 15 to 20 minutes after second adenoma removal.
CONCLUSION: Our results provide evidence that the decrease in serum intact PTH due to minimally invasive parathyroidectomy results in an immediate decrease in serum MCP-1 levels.

Entities:  

Year:  2014        PMID: 24936562     DOI: 10.4158/EP14104.OR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  8 in total

Review 1.  Parathyroid hormone: anabolic and catabolic actions on the skeleton.

Authors:  Barbara C Silva; John P Bilezikian
Journal:  Curr Opin Pharmacol       Date:  2015-04-05       Impact factor: 5.547

2.  Serum Klotho levels in primary hyperparathyroidism patients before and after parathyroidectomy.

Authors:  Chi Su; Lingqiong Meng; Stanley Z Trooskin; Sue A Shapses; Yuling He; Aseel Al-Dayyeni; Xiangbing Wang
Journal:  Endocrine       Date:  2020-07-24       Impact factor: 3.633

3.  Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation.

Authors:  L Osagie-Clouard; A Sanghani; M Coathup; T Briggs; M Bostrom; G Blunn
Journal:  Bone Joint Res       Date:  2017-01       Impact factor: 5.853

Review 4.  CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone.

Authors:  Jawed Akhtar Siddiqui; Nicola C Partridge
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-29       Impact factor: 5.555

5.  Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism.

Authors:  Jawed A Siddiqui; Joshua Johnson; Carole Le Henaff; Claudine L Bitel; Joseph A Tamasi; Nicola C Partridge
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

6.  Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level.

Authors:  Ahmed Zahran; Ahmed Attia; Holly Mansell; Ahmed Shoker
Journal:  J Inflamm (Lond)       Date:  2018-09-10       Impact factor: 4.981

7.  Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling.

Authors:  Jawed A Siddiqui; Carole Le Henaff; Joshua Johnson; Zhiming He; Daniel B Rifkin; Nicola C Partridge
Journal:  Bone       Date:  2020-11-17       Impact factor: 4.398

Review 8.  Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis.

Authors:  Bridie S Mulholland; Mark R Forwood; Nigel A Morrison
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.